Literature DB >> 2432724

Biological tissue markers in benign and malignant disease of the human prostate.

P Chastonay, J Hurlimann, D Gardiol.   

Abstract

Immunoperoxidase techniques were used to study, the distribution of peanut agglutinin receptors, blood group isoantigens and several epithelial antigens in hyperplasia, adenosis, microcarcinoma and well differentiated adenocarcinoma of the prostate. Intraluminal and luminal surface PNA receptors were seen in all well differentiated carcinomas, 53% of microcarcinomas and 50% of adenosis, while no such sites could be demonstrated in benign hyperplasia. The expected blood group isoantigen was expressed in 75% of benign hyperplasias. When compared to the hyperplastic epithelium nearby, appropriate ABH expression was seen in 60% of adenosis, 47% of microcarcinomas and 25% of well differentiated carcinomas. A keratin antibody specifically labelling the basal cells in the normal prostate identified a subset of well differentiated carcinomas with preferential staining of the apical cytoplasm while microcarcinomas and adenosis were consistently negative. Our study establishes a highly ordered PNA receptor distribution in prostatic epithelia; it confirms early changes in the expression of ABH isoantigens in epithelial proliferative disorders of the prostate; it identifies a subset of keratin-positive well differentiated carcinomas, possibly of different ontogeny.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432724     DOI: 10.1007/bf00710828

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  42 in total

1.  Reactive properties of oral lesions to the specific red cell adherence test.

Authors:  D I George; N J Burzynski; R L Miller
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1979-01

2.  Atypical epithelial hyperplasia or carcinoma of prostate gland: the surgical pathologist at an impasse?

Authors:  M Tannenbaum
Journal:  Urology       Date:  1974-12       Impact factor: 2.649

3.  Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii.

Authors:  K Akazaki; G N Stemmerman
Journal:  J Natl Cancer Inst       Date:  1973-05       Impact factor: 13.506

4.  Correlations between atypical primary hyperplasia and carcinoma of the prostate. A histological study of 180 total prostatectomies.

Authors:  H Kastendieck
Journal:  Pathol Res Pract       Date:  1980-11       Impact factor: 3.250

5.  The biological significance of atypical hyperplasia of the prostate.

Authors:  B Helpap
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

6.  Well differentiated adenocarcinoma of the prostate.

Authors:  W H Kern
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

7.  Immunohistochemical localization of keratin in normal human tissues.

Authors:  R Schlegel; S Banks-Schlegel; G S Pinkus
Journal:  Lab Invest       Date:  1980-01       Impact factor: 5.662

8.  Keratin immunoreactivity in the benign and neoplastic human prostate.

Authors:  M K Brawer; D M Peehl; T A Stamey; D G Bostwick
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

9.  Age-dependent changes in the carbohydrate pattern of human prostatic epithelium as determined by peroxidase-labeled lectins.

Authors:  W Bischof; G Aumüller
Journal:  Prostate       Date:  1982       Impact factor: 4.104

10.  Keratin filaments of cultured human epidermal cells. Formation of intermolecular disulfide bonds during terminal differentiation.

Authors:  T T Sun; H Green
Journal:  J Biol Chem       Date:  1978-03-25       Impact factor: 5.157

View more
  5 in total

1.  Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland.

Authors:  F P O'Malley; D J Grignon; D T Shum
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Connective tissue protein in the prostate gland.

Authors:  T Nakada; Y Kubota
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

3.  ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity.

Authors:  Donatas Stakišaitis; Milda Juknevičienė; Albertas Ulys; Dalia Žaliūnienė; Daiva Stanislovaitienė; Ramunė Šepetienė; Anželika Slavinska; Kęstutis Sužiedėlis; Vita Lesauskaitė
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

4.  Evaluation of three techniques for differential diagnosis of prostatic needle biopsy specimens.

Authors:  R F McMahon; L J McWilliam; S Mosley
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

Review 5.  The role of the histoblood ABO group in cancer.

Authors:  Seth K Rummel; Rachel E Ellsworth
Journal:  Future Sci OA       Date:  2016-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.